Status:
UNKNOWN
Controlled Internal Convection in Low Flow Hemodialysis of Dialysate: Removal of Beta-2-microglobulin
Lead Sponsor:
University Hospital, Caen
Conditions:
Daily Home Hemodialysis
Eligibility:
All Genders
18-80 years
Phase:
NA
Brief Summary
Since 2013 daily home hemodialysis allows low volumes of convection. This study is a prospective cross-over trial testing the efficiency of internal convection on Beta2-microglobulin in daily home hem...
Detailed Description
Daily home hemodialysis with low dialysate volume system does not normally allow convection. Middle molecular weight toxins clearance is therefore lower. Beta2-microglobulin is considered representati...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- home hemodialysis since at least 2 weeks
- hemodialysis since at least 3 months
Exclusion
Key Trial Info
Start Date :
May 9 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
September 1 2022
Estimated Enrollment :
16 Patients enrolled
Trial Details
Trial ID
NCT05419271
Start Date
May 9 2022
End Date
September 1 2022
Last Update
June 15 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
CHU Caen Normandie
Caen, France, 14000